A boronic acid conjugation integrates antitumor drugs into albumin-binding prodrugs-based nanoparticles with robust efficiency for cancer therapy
暂无分享,去创建一个
J. Sun | Guorui Zhu | Zhonggui He | Mengchi Sun | Maosheng Cheng | Qiuhua Luo | Weiyue Ban | Chengda Yan | Xiaoying Fan
[1] Yongbing Chen,et al. Reactive oxygen species-responsive branched poly (β-amino ester) with robust efficiency for cytosolic protein delivery. , 2022, Acta biomaterialia.
[2] J. Sun,et al. Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy , 2022, Nano Research.
[3] Man Li,et al. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge". , 2021, ACS applied materials & interfaces.
[4] Aysha Sarfraz Rizvi,et al. Determination of glycated albumin in serum and saliva by capillary electrophoresis utilizing affinity of 3-acrylamido phenylboronic acid selected by virtual screening and molecular docking. , 2020, Journal of chromatography. A.
[5] Fang Lan,et al. Intermolecular B-N coordination and multi-interaction synergism induced selective glycoprotein adsorption by phenylboronic acid-functionalized magnetic composites under acidic and neutral conditions. , 2020, Journal of materials chemistry. B.
[6] H. Kim,et al. Protein-Based Nanoparticles as Drug Delivery Systems , 2020, Pharmaceutics.
[7] D. Mobley,et al. Non-bonded force field model with advanced restrained electrostatic potential charges (RESP2) , 2020, Communications Chemistry.
[8] Yuan Ping,et al. A boronic acid–rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing , 2019, Science Advances.
[9] C. Duvall,et al. Harnessing albumin as a carrier for cancer therapies , 2018, Advanced drug delivery reviews.
[10] Xuesi Chen,et al. High Drug Loading and Sub-Quantitative Loading Efficiency of Polymeric Micelles Driven by Donor-Receptor Coordination Interactions. , 2018, Journal of the American Chemical Society.
[11] G. Storm,et al. The battle of “nano” paclitaxel , 2017, Advanced drug delivery reviews.
[12] Song Lin,et al. The Cation-π Interaction in Small-Molecule Catalysis. , 2016, Angewandte Chemie.
[13] R. Alemany,et al. Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[14] Michael R Hamblin,et al. Albumin nanostructures as advanced drug delivery systems , 2016, Expert opinion on drug delivery.
[15] Xiaoyuan Chen,et al. Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy. , 2016, Chemical Society reviews.
[16] X. Wang,et al. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. , 2013, Biomaterials.
[17] Wim F Vranken,et al. ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.
[18] Tian Lu,et al. Multiwfn: A multifunctional wavefunction analyzer , 2012, J. Comput. Chem..
[19] Roman A. Laskowski,et al. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..
[20] Patrick Soon-Shiong,et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] F. Atyabi,et al. Clinical applications of nanomedicine in cancer therapy. , 2019, Drug discovery today.
[22] Baorui Liu,et al. The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors. , 2014, Biomaterials.